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resenilin 1 (PS1) interacts with telencephalin (TLN)
and the amyloid precursor protein via their trans-
membrane domain (Annaert, W.G., C. Esselens, V.
Baert, C. Boeve, G. Snellings, P. Cupers, K. Craessaerts,
and B. De Strooper. 2001. 
 
Neuron
 
. 32:579–589). Here, we
demonstrate that TLN is not a substrate for 
 
 
 
-secretase
cleavage, but displays a prolonged half-life in PS1
 
 
 
/
 
 
 
 hip-
pocampal neurons. TLN accumulates in intracellular struc-
tures bearing characteristics of autophagic vacuoles including
the presence of Apg12p and LC3. Importantly, the TLN ac-
cumulations are suppressed by adenoviral expression of
wild-type, FAD-linked and D257A mutant PS1, indicating
P
 
that this phenotype is independent from 
 
 
 
-secretase activity.
Cathepsin D deﬁciency also results in the localization of
TLN to autophagic vacuoles. TLN mediates the uptake of
microbeads concomitant with actin and PIP2 recruitment,
indicating a phagocytic origin of TLN accumulations. Ab-
sence of endosomal/lysosomal proteins suggests that the
TLN-positive vacuoles fail to fuse with endosomes/lyso-
somes, preventing their acidiﬁcation and further degradation.
Collectively, PS1 deﬁciency affects in a 
 
 
 
-secretase–inde-
pendent fashion the turnover of TLN through autophagic
vacuoles, most likely by an impaired capability to fuse with
lysosomes.
 
Introduction
 
Presenilin 1 and 2 (PS1/2) play a catalytic role in the 
 
 
 
-sec-
retase complex needed for regulated intramembrane pro-
teolysis of the amyloid precursor protein (APP; for review
see Annaert and De Strooper, 2002; Selkoe and Kopan,
2003). This event results in the final liberation of the amy-
loid 
 
  
 
(A
 
 
 
) peptide. For its activity it requires the coordi-
nated action of essential components including nicastrin,
pen-2, and aph1. These proteins incorporate into a high mo-
lecular weight complex and depend on each other for their
maturation, endoproteolysis, and stability (for review see De
Strooper, 2003). The aspartate 257 and 385 (amino acid
numbering of human PS1) most probably form the cata-
lytic core of this complex (Wolfe et al., 1999). Next to APP,
the 
 
 
 
-secretase complex is responsible for intramembrane
proteolysis of a growing list of type I integral membrane
proteins (for review see Annaert and De Strooper, 2002;
Selkoe and Kopan, 2003). This mediates a multitude of
downstream signaling cascades, either by generating an intra-
cellular domain that acts as a transcriptional (co)factor or by
regulating the availability of associated protein networks.
Next to 
 
 
 
-secretase cleavage, PSs are implicated in at least
two other pathways. Koo and coworkers demonstrated that
PS1 is a negative regulator of the Wnt/
 
 
 
-catenin signaling
pathway mediating the degradation of 
 
 
 
-catenin indepen-
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dent from the Axin/CK1
 
 
 
 route (Kang et al., 2002). Sec-
ond, PSs modulate capacitative calcium entry, a refilling
mechanism for depleted intracellular calcium stores (Yoo et
al., 2000). Furthermore, PS1 may regulate the trafficking of
selected transmembrane proteins such as TrkB (Naruse et
al., 1998), but also APP (Cai et al., 2003; Kaether et al.,
2002) and nicastrin (for review see De Strooper, 2003).
From these analyses it was suggested that PS1 modulates the
trafficking in the early secretory pathway or during internal-
ization at the cell surface, but in most cases this could not
be clearly dissociated from its stabilizing or catalytic role in
 
 
 
-secretase. The molecular basis for a trafficking role of PS1
is still far from being elucidated.
We documented before (Annaert et al., 2001) the interac-
tion of PS1with telencephalin (TLN), a neuron-specific in-
tercellular adhesion molecule (ICAM-5; Gahmberg, 1997)
involved in dendritic outgrowth (Tian et al., 2000) and
long-term potentiation (Nakamura et al., 2001). As for
APP, the interaction is mediated through the PS1 COOH
terminus and the first transmembrane domain, which may
form a binding pocket with the transmembrane region of
TLN. These findings have led us to propose a ring structure
topology for PS1 in which the catalytic and substrate-bind-
ing site are spatially separated (Annaert et al., 2001). In
PS1
 
 
 
/
 
 
 
 hippocampal neurons, TLN accumulates in large so-
matic structures, coupling PS1 function to TLN localization
and trafficking. However, both the nature of these accumu-
lations as well as the question whether they originate as a di-
rect consequence of impaired 
 
 
 
-secretase processing of TLN
remained unsolved.
Using independent approaches, we now demonstrate that
TLN is not a regulated intramembrane proteolysis substrate.
We confirm that its accumulation in PS1-deficient neurons
is not modulated by 
 
 
 
-secretase inhibitors and can be res-
cued by adenoviral expression of wild-type, FAD-linked and
D257A mutant PS1. In fact, full-length TLN displays a de-
layed turnover and accumulates in an intracellular compart-
ment in the absence of PS1. Here, we demonstrate that this
compartment displays several features reminiscent of au-
tophagic vacuoles. Autophagy is one of the major pathways
of degradation of intracellular proteins. It thereby contrib-
utes to the balance between protein synthesis and degrada-
tion, which is essential in the control of growth and metabo-
lism of cells. Autophagic vacuole formation in neurons is
poorly understood, and it has been suggested that it may
play a temporary protective role in early stages of apoptosis
or even delay apoptosis (Jellinger and Stadelmann, 2000).
Interestingly, the TLN accumulations are not acidified and
do not acquire endosomal/lysosomal components, suggest-
ing a failure of lysosomal fusion. Finally, we propose a
phagocytic origin of these accumulations based on the mi-
crobead uptake experiments in neurons. Together, our data
link PS1 to an autophagic degradative route distinct from its
 
 
 
-secretase function.
 
Results
 
TLN is not cleaved by 
 
 
 
-secretase
 
In wild-type hippocampal neurons, TLN localizes to the
plasmalemma, whereas in 30% of PS1
 
 
 
/
 
 
 
 neurons, TLN
additionally accumulates in large somatic structures (Fig.
1), the identity of which remained elusive (Annaert et
al., 2001). To our surprise, APP, a substrate for 
 
 
 
-secre-
tase, did not coenrich in these structures, suggesting that
PS1 deficiency affects APP and TLN differentially. There-
fore, we tested whether TLN is a 
 
 
 
-secretase substrate. In
15-d-old PS1
 
 
 
/
 
 
 
 hippocampal cultures we could not de-
tect any TLN COOH-terminal fragment (CTF), as op-
posed to APP-CTF, which readily accumulates (Fig. 2
A). Even upon Semliki Forest virus (SFV)–induced over-
expression, no TLN-CTF was detected. Because no puta-
tive mechanism of shedding of the TLN ectodomain is
known, we generated a TLN
 
 
 
E that could serve as a po-
tential 
 
 
 
-secretase substrate. However, no intracellular do-
main fragments were detected, indicating the absence of
 
 
 
-secretase cleavage. Because this could reflect a fast turn-
over of the intracellular domain after cleavage, as seen for
Notch and APP, we used a highly sensitive reporter assay
(Struhl and Adachi, 2000) by coupling the Gal4VP16
transactivator to the cytoplasmic domain of TLN. Release
Figure 1. Full-length TLN (but not APP) 
accumulates in a distinct compartment in 
PS1
 /  hippocampal neurons. Double-immu-
nofluorescence staining for endogenous TLN 
(green, B36.1) and APP (red, mAb C1 6.1) in 
wild-type (top) and PS1
 /  (bottom) hippo-
campal neurons (15-d culture). The inset shows 
an overview of the neuron. In wild-type neurons 
TLN labeling is essentially localized to the 
somatodendritic plasmalemma in contrast to 
APP, which is found in intracellular compart-
ments. In addition, PS1 deficiency causes 
TLN, but not APP, to cluster in large somatic 
accumulations. Bars, 10  m. 
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Figure 2. TLN lacks the characteristics of a  -secretase substrate. (A) Western blot analysis of endogenous TLN and APP in wild-type and 
PS1
 /  hippocampal neurons. PS1 deficiency results in the accumulation of APP-CTF. No TLN-CTF (estimated   7 kD) was detected, neither 
was it detected after SFV-induced exogenous overexpression. Also, overexpression of a TLN E fragment did not generate a PS1-dependent 
TLN intracellular domain. (B) Different constructs fused to the Gal4VP16 domain were used in a  -secretase reporter assay. Control transfec-
tions (pIPspAdApt empty vector and pIPspAdApt-APP without Gal4VP16) show no luciferase activity. APP-Gal4VP16 and Notch E-Gal4VP16 
activate the luciferase gene upon cleavage and are inhibited by DAPT, L658,458, or compound 32 (125 nM). No luciferase activity was 
detected using TLN E or APP in which the transmembrane domain was replaced by that of TLN (APP/TLNTMR chimaera), indicating that 
this region is not cleaved by  -secretase. (C) Left:  -secretase inhibitors do not induce the formation of TLN accumulations. Wild-type hip-
pocampal neurons were treated with  -secretase inhibitors (125 nM, daily from d 7–14 post-plating), fixed, and immunostained for TLN 
and the percentage of neurons with TLN accumulations was scored. Culturing neurons for 25 d increases the size and number (insets), but 
not the frequency of TLN accumulations (mean   SEM, n   3, 200–700 neurons per time point). Right: Western blot showing that only APP-
CTF accumulates after chronic treatment with  -secretase inhibitors. (D) Adenoviral reintroduction of human PS1 suppresses TLN accumula-
tions. 30–35% of PS1
 /  neurons display TLN accumulations, in contrast to  5% in PS1
 /  and 
 /  cultures as well as in cultures expressing 
human PS1 in a PS1
 /  background. However, suppression of TLN accumulations was obtained by adenoviral introduction of human PS1. 
A clear dose-dependent inhibition was seen with increasing MOI of adenoviral (AV) human PS1, but also the familial Alzheimer’s disease-
linked PS1G384A and dominant-negative PS1D257A mutants. Control adenoviral infections with eGFP did not have a significant effect. 
After 9–11 d post-infection (15 d post-plating), neurons displayed significant PS1 protein expression as demonstrated by double staining 
for TLN and human PS1(mAb 5.2). Bars, 20  m. 
1044 The Journal of Cell Biology 
 
|
 
 
 
Volume 166, Number 7, 2004
 
of a potential intracellular domain of TLN can be mea-
sured via the activity of luciferase. Although for APP and
Notch, nuclear translocation of the inducer fragment was
prominent, and strongly inhibited by different 
 
 
 
-secretase
inhibitors (125 nM DAPT, L685,458, or compound C),
no signal could be detected with TLN
 
 
 
E-Gal4VP16 (Fig.
2 B). To investigate whether the TLN transmembrane do-
main could be a 
 
 
 
-secretase substrate in the context of the
APP protein, we swapped the transmembrane regions of
TLN and APP to create an APP/TLN
 
TMR
 
-chimaera. Even
in this case no activity could be detected (Fig. 2 B). There-
fore, we conclude that TLN is most likely not a 
 
 
 
-secre-
tase substratum.
Finally, we investigated to what extent the TLN accu-
mulations depended on 
 
 
 
-secretase activity. Treatment of
wild-type neurons with 
 
 
 
-secretase inhibitors for 1 wk (daily
administered from d 7–14) did not induce aberrant TLN ac-
cumulations (Fig. 2 C, left), although 
 
 
 
-secretase cleavage of
APP-CTF was markedly inhibited (Fig. 2 C, right).
Of notice, in 25-d-old PS1
 
 
 
/
 
 
 
 neurons the frequency of
TLN accumulations did not further increase. Instead, in in-
dividual neurons they tended to be more numerous (grape-
like) or larger (suggesting they may undergo fusion) (insets
in Fig. 2 C). These accumulations were not encountered in
PS1
 
 
 
/
 
 
 
 neurons nor in neurons expressing human PS1 in a
PS1
 
 
 
/
 
 
 
 background (Qian et al., 1998). However, a true res-
Figure 3. Turnover of full-length TLN is altered in PS1
 /  neurons. Wild-type and PS1
 /  cortical neurons were transduced with SFV-TLN 
(A) or -APP (B), pulse labeled for 15 min with [
35S]methionine, and chased for different time periods. Immunoprecipitated TLN and APP were 
treated with EndoH and analyzed by SDS-PAGE and phosphorimaging. The accumulation of an EndoH-resistant band indicates progressive 
maturation during Golgi passage; however, the ratio of EndoH-resistant to -sensitive TLN (A, top) and APP (B, top) revealed no difference 
(mean   SEM, n   3). Instead, the half-life of overexpressed TLN (A, bottom), but not full-length APP (B, bottom), is significantly prolonged in 
PS1
 /  neurons (mean   SEM, n   3). (C) Wild-type and PS1
 /  hippocampal neurons (12 d) were scraped, pelleted, and treated with 10 mU 
EndoH, followed by Western blot detection of APP, TLN, PS1, nicastrin (NCT), synaptophysin, and ductin. TLN levels are increased almost 
fourfold in PS1
 /  neurons. No EndoH-sensitive TLN was detected in PS1
 /  neurons, indicating a complete maturation. APP-CTF shows a 
dramatic accumulation (44-fold; mean   SEM, n   3). 
PS1-dependent turnover of telencephalin |
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cue was achieved by reintroducing human PS1 using adeno-
viral infection (Michiels et al., 2002). Increasing the multi-
plicity of infection (MOI) from 250 to 6,000 virus particles/
neuron suppressed the frequency of TLN accumulations to
wild-type levels (Fig. 2 D). Importantly, similar rescue ef-
fects were obtained with FAD-linked G384A or D257A
dominant-negative PS1 mutants, arguing again for a 
 
 
 
-sec-
retase–independent effect of PS1. Because TLN accumu-
lations only appeared in 
 
 
 
30% of PS1
 
 
 
/
 
 
 
 neurons, this full
rescue could only be achieved with a very high transfection
efficiency. Control adenoviral expression of eGFP indeed re-
sulted in an 85–95% efficiency (unpublished data). More-
over, protein expression lasted up to 11 d after infection as
shown for PS1 (Fig. 2 D). In summary, exogenous expres-
sion of wild-type or mutant PS1 is sufficient to restore the
aberrant TLN phenotype.
 
The turnover of full-length TLN is affected in 
PS1
 
 
 
/
 
 
 
 neurons
 
As PS1 is abundantly localized in pre-Golgi compartments
(Annaert et al., 1999; Rechards et al., 2003), TLN accumula-
tions may reflect a transport block in the early secretory path-
way due to the absence of PS1. We tested this by analyzing
the glycosylation kinetics of TLN. We overexpressed TLN
using the SFV system in wild-type and PS1
 
 /  cortical neu-
rons and performed pulse-chase experiments in combination
with endoglycosidase H (EndoH) treatment to quantify the
ratio of mature to immature glycosylated TLN (Fig. 3 A).
Phosphorimaging analysis revealed no statistical differences
in this ratio, indicating that transport kinetics of newly syn-
thesized TLN are similar in wild-type and PS1
 /  neurons, as
was seen for APP (Fig. 3 B; De Strooper et al., 1998).
However, using the same pulse-chase paradigm, we found
that the half-life of newly synthesized TLN, but not full-
length APP, was delayed in PS1
 /  neurons (Fig. 3, A and
B; bottom). If turnover is delayed, this should be reflected in
a relative increase of endogenous TLN in PS1
 /  neurons.
Indeed, Western blotting and densitometric analysis showed
an almost fourfold increase of TLN compared with wild-
type neurons (Fig. 3 C). Interestingly, TLN appeared to be
endoH resistant, suggesting that TLN accumulation occurs
in post-Golgi compartments. Further controls indicated a
weak accumulation of full-length APP and an impressive 44-
fold increase in APP-CTF.
Figure 4. TLN accumulation occurs in a com-
partment distinct from classic biosynthetic and 
endosomal pathways. (A–F) Early compartments. 
No colocalization was observed between TLN 
(green in all panels) and nuclei (A, TOPRO-3), 
ER-markers BIP (B) and calnexin (C), ERGIC-53 
(D),  -COP (E) or GM130 (F), and labeling cis-
Golgi. (G–L) Late compartments. TLN accumu-
lations are not accessible for exogenous biotin 
(G). Early and recycling endosomes (H, EEA1) 
and transferrin receptor (I, TFR), late endosomes 
(J, LBPA), and lysosomes (K, Lamp-2; L, catD) 
also stained negative for TLN. Vertical sections 
(x–z, arrowheads in I and J) clearly distinguish 
TLN accumulations from recycling (I, TFR) and 
late endosomes (J, LBPA). Bars, 10  m.1046 The Journal of Cell Biology | Volume 166, Number 7, 2004
TLN accumulations do not codistribute with 
“classical” early and late compartments
To understand the possible mechanism(s) behind the in-
creased protein levels and delayed turnover, we set out to
identify the compartment where TLN accumulates in PS1
 / 
neurons. First, TLN accumulations could not be identified
as nuclear inclusions (Fig. 4 A), and essentially no overlap
was detected with marker proteins of the ER such as BIP and
calnexin (Fig. 4, B and C). Other compartments of the early
secretory pathway, including the intermediate compartment
(ERGIC-53) and Golgi apparatus ( -COP and GM130),
were equally devoid of TLN immunostaining (Fig. 4, D–F).
Figure 5. Correlative light immuno-EM analysis of TLN accumulations. (A) Insert: overview of the selected neuron as seen by immunocy-
tochemistry. The bright signal for TLN reflects the numerous membranous accumulations seen at the ultrastructural immuno-EM level (star). 
(B) Higher magnification of the boxed area in A. (C) High magnification of the boxed structure seen in B. 10-nm gold particles label TLN. 
Note the complex composition of the internal membranes of the TLN-positive compartments. (D) Example of a TLN (15-nm gold)-containing 
structure obtained by the conventional cryosectioning technique. Note some heterogeneity in the internal membranes between C and D. 
Lamp-1 (10-nm gold) is absent from the TLN-containing compartment. Arrows point to invaginations of the cytoplasm. N, nucleus; P, plasma 
membrane. Bars: A, 5  m; B, 2  m; C, 500 nm; D, 200 nm.PS1-dependent turnover of telencephalin | Esselens et al. 1047
Although TLN accumulations are found close beneath the
cell surface (Annaert et al., 2001), they were not accessible to
exogenous biotin (Fig. 4 G). We detected no association
with early (EEA1) or recycling endosomes (transferrin recep-
tor) (Fig. 4, H and I), nor with late endosomes (LBPA) and
lysosomes (Lamp-2 and cathepsin D [catD]).
These findings encouraged us to implement EM. Due to
the specifications of the culture, we applied a new flat-
embedding technique that preserves the in situ orientation
of polarized neurons (Oorschot et al., 2002), and com-
bined this with correlative light immuno-EM (Koster and
Klumperman, 2003). This allowed us to localize TLN ac-
cumulations before EM processing (Fig. 5, inset). Im-
muno-EM revealed abundant gold label at the plasma-
lemma and in large membrane-bound vacuoles. In these
structures, label was found both on the limiting membrane
and internal membranes. Interestingly, LAMP-1 labeled
lysosomes, but not TLN positive structures (Fig. 6), con-
firming that they are distinct from (pre)lysosomal compart-
ments. Except for their large size, their heterogeneous
content including tubular and vesicular structures is sugges-
tive for an autophagic origin.
Characterization of TLN-positive autophagic vacuole-
like structures
Autophagy is the intracellular bulk degradation system and
plays an important role in the cellular protein economy (Mi-
zushima et al., 2002). To further identify TLN-positive
structures, we first analyzed the uptake of monodansylcadav-
erine (MDC), a compound used to identify autophagic vac-
uoles (Munafo and Colombo, 2001). MDC coaccumulated
with TLN in PS1
 /  neurons (Fig. 7 A). Noteworthy,
MDC uptake occurred in the absence of starvation, indicat-
ing that TLN accumulations are preexisting structures.
Autophagic vacuoles originate from an elongation process
of isolation membranes that close and finally fuse with late
endosomes/lysosomes (Mizushima et al., 2002). Several
ubiquitin-like conjugation systems are essential for auto-
phagic vacuole formation. Among them, the Apg12p–Apg5p
conjugate is important in the initial steps where it localizes
(albeit a small fraction) to the outer side of the isolation
membrane throughout the elongation process, and dissoci-
ates again upon completion of the autophagic vacuole (Mi-
zushima et al., 2001). A second protein is LC3 (Kabeya et
al., 2000), which remains partially on the autophagic vacu-
ole even after fusion with lysosomes. In PS1
 /  neurons,
both anti-Apg12p and -LC3 antibodies immunostained
TLN accumulations (Fig. 7, B and C). However, Apg12p
remains stably associated with these structures, which is sur-
prising because this protein is reported to dissociate before
or upon closure of the autophagic vacuole. This suggests
that the normal formation and maturation of this type of au-
tophagic vacuole is impaired in PS1
 /  neurons. In wild-
type neurons, no colocalization of Apg12p and LC3 with
TLN was observed (Fig. 7, B and C, top row), demonstrat-
ing the unique nature of the accumulations. Interestingly, in
some PS1
 /  neurons small TLN- and Apg12p-positive
structures were detected in the proximal regions of den-
drites, possibly representing earlier stages of accumulation
(Fig. 7 B, bottom row).
TLN localizes to autophagic vacuoles in catD
 /  
hippocampal neurons
These surprising findings prompted us to investigate in
more detail the relationship of TLN with autophagic vacu-
oles. In many cases, autophagic vacuole accumulation is as-
sociated with defective lysosomal biogenesis (Koike et al.,
2000; Eskelinen et al., 2002). However, in our case no dif-
ference in catD maturation was found between wild-type
and PS1
 /  neurons, and lysosomal delivery of catD is
therefore not impaired (Fig. 8 A). On the other hand, catD
deficiency results in the accumulation of autophagic vacu-
oles/autophagosomes (Koike et al., 2000). This is also true
in primary hippocampal neurons derived from catD
 /  em-
bryos, as can be observed with Lysotracker (Fig. 8 B). Al-
though TLN accumulations are clearly not acidified in
PS1
 /  neurons (Fig. 8 C), acidic organelles were often
found in close apposition and likely represent lysosomes
(Fig. 6). Surprisingly, in catD
 /  neurons some TLN immu-
noreactivity was detected in the large Lysotracker-positive
organelles (Fig. 8 C, bottom). Ultrastructurally, these TLN-
positive organelles resemble dense autophagic vacuole-like
structures (Fig. 8 D). Importantly, these organelles are
smaller in diameter compared with TLN accumulations and
were not seen in wild-type or PS1
 /  neurons. Together, in
catD
 /  neurons TLN localizes to autophagic vacuoles, sug-
gesting that these organelles are part of the normal physio-
logical route for TLN degradation.
Figure 6. TLN accumulations are distinct from lysosomes. A TLN 
(15-nm gold)-containing structure as obtained by the conventional 
cryosectioning technique double labeled with Lamp-1 (10-nm gold). 
The TLN-positive compartment is clearly distinct in size and from 
lysosomes (L) and lacks Lamp-1. P, plasma membrane. Bar, 200 nm.1048 The Journal of Cell Biology | Volume 166, Number 7, 2004
TLN mediates phagocytic uptake of microbeads in 
primary hippocampal neurons
We have shown that TLN accumulations do not share
endosomal/lysosomal components. Also, TLN normally
localizes to the somatodendritic plasma membrane and
accumulates as a mature protein (Fig. 3 C), suggesting
that accumulations originate from the plasma membrane
through an internalization event distinct from endocytosis.
To test whether phagocytosis is involved, we triggered this
process by challenging hippocampal neurons with 2- m
microbeads. After 4 h, many beads were already found as-
sociated with neurites, and recruited TLN immunoreactiv-
ity (Fig. 9 A, top). Longer incubations (24 or 48 h; Fig. 9
A, bottom) resulted in a complete redistribution of TLN to
microbeads. Because actin polymerization is considered the
driving force of phagosome cup formation (May and Ma-
chesky, 2001), we costained with phalloidin-Alexa 568.
Actin polymerization clearly colocalizes in a ring- or cup-
shaped pattern with TLN on individual microbeads (Fig. 9
B; Video 1, available at http://www.jcb.org/cgi/content/
full/jcb.200406060/DC1). Although the exact mechanism
in phagosome formation is not clear, regulation by local
phosphoinositide production is crucial in actin polymeriza-
tion. Indeed, and next to actin, also endogenous phos-
phatidylinositol 4,5 bisphosphate (PIP2) is recruited to the
TLN-positive phagosomal cup (Fig. 9 C, arrowheads in
boxed area). Interestingly, PIP2 also colocalized to discrete
TLN spots probably representing normal plasma mem-
brane localization of TLN (Fig. 9 C, asterisk). Notably,
levels of PIP2 between different TLN-positive microbeads
were sometimes very variable. This may reflect different
stages of phagosome formation because PIP2 is rapidly lost
upon phagosome sealing and completion due to the re-
cruitment of PLC (Botelho et al., 2000). In agreement
Figure 7. TLN accumulations have characteristics of 
autophagic vacuoles. (A) Wild-type and PS1
 /  hippo-
campal neurons (15 d) were incubated with 50 mM 
MDC, fixed, and counterstained with anti-TLN (red). 
Uptake of MDC was only apparent in PS1
 /  neurons 
where it colocalized with TLN accumulations (arrow-
heads). Bar, 10  m. (B and C) Double immunostaining 
of wild-type and PS1
 /  hippocampal neurons for TLN 
(green) and autophagic vacuole-associated Apg12p 
(B) and LC3 (C). To detect both sets of pAbs, an alter-
native method was developed using biotinylated anti-
TLN (see Materials and methods). Each experiment 
included controls for specificity (not depicted). In 
wild-type neurons, both Apg12p and LC3 (B and C, 
top row) were broadly distributed in cell bodies and 
neurites, but did not colocalize with TLN. Colocaliza-
tion was only observed in multiple TLN accumulations 
in PS1
 /  hippocampal neurons (second row in B and 
C, respectively). For Apg12p, coimmunostaining was 
also noticed in small discrete structures in the proximal 
dendrites (B, bottom row). Bars, 10  m.PS1-dependent turnover of telencephalin | Esselens et al. 1049
with this, no (or almost no) PIP2 was detected on TLN ac-
cumulations in PS1
 /  neurons. Microbead uptake was
equally observed both in wild-type and PS1
 /  neurons,
indicating that this phagocytic process most likely does not
require PS1. Nevertheless, our data may provide a first in-
sight in the initial steps of the subcellular route that leads
to the aberrant TLN phenotype in PS1
 /  hippocampal
neurons.
Figure 8. CatD
 /  hippocampal neu-
rons as a model system for autophagic 
vacuole accumulation. (A) Intracellular 
sorting and maturation of catD. Wild-
type and PS1
 /  neurons were metaboli-
cally labeled and chased for the indi-
cated time periods. Phosphorimaging of 
immunoprecipitated radiolabeled catD 
did not reveal a difference in the ratio of 
proteolytically processed 46-kD inter-
mediate vs. 52-kD precursor (mean   
SEM, n   3). (B–D) TLN localizes to 
autophagic vacuoles of catD 
 /  hippo-
campal neurons. Lysotracker staining 
revealed sparsely distributed small-
sized organelles in wild-type and PS1
 /  
neurons in contrast to catD
 /  neurons 
where high numbers of large Lysotracker-
positive organelles were found (B, arrow-
heads). Although TLN accumulations in 
PS1
 /  were fully negative for Lysotracker, 
some acidic organelles tended to closely 
associate (C, arrowheads, middle). In 
catD
 /  neurons, TLN was clearly de-
tected in the large acidic organelles 
(C, bottom). Bars, 20  m. (D) At the 
immuno-EM level, the large acidic 
organelles seen in catD
 /  neurons rep-
resent dense autophagic vacuole-like 
structures (star) that label positive for 
TLN (10-nm gold). M, mitochondrion. 
Bars, 200 nm.1050 The Journal of Cell Biology | Volume 166, Number 7, 2004
Figure 9. TLN mediates phagocytic uptake of microbeads in hippocampal neurons. (A) Microbeads align along neurites of hippocampal 
neurons as demonstrated by phase contrast (DIC). Already after 4 h, many beads stain positive for TLN (arrowheads, top). At 48 h (bottom), 
most TLN immunoreactivity was associated with microbeads at the expense of its typical plasma membrane staining. *, cell body. Note that 
microbeads were not found associated with preexisting TLN accumulations (asterisk in top panels, 4 h). (B) Microbeads (24 h) accumulate 
TLN and actin, as shown by phalloidin-Alexa 568. An overview of the neuron is given in each top left inset, next to two detailed areas (white 
boxes). The differential interference contrast (DIC) clearly demonstrates a complete colocalization of microbeads with TLN and phalloidin 
(arrowheads). TOPRO-3 (blue) marks the nucleus (see also Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb.200406060/DC1). (C) 
Similar as in B, but immunostained for TLN and endogenous PIP2. The overview demonstrates the overall recruitment of PIP2 to microbeads 
(arrows). The parallel insets show a detailed area (white box) with PIP2 being colocalized with TLN on individual microbeads (arrowheads). 
Note that PIP2 occasionally colocalizes with TLN at the plasma membrane (asterisk). Bars (A–C), 10  m.PS1-dependent turnover of telencephalin | Esselens et al. 1051
Discussion
We previously documented the specific interaction of APP
and TLN with PS1 in neurons (Annaert et al., 2001), while
leaving open two major issues concerning  -secretase pro-
cessing and missorting of TLN in PS1
 /  neurons. Here, we
demonstrate convincingly that TLN is not a  -secretase sub-
strate (which is surprising given the growing list of type I in-
tegral membrane proteins that are cleaved by this activity),
and identify important steps in the transport route that ulti-
mately result in TLN accumulations. First, we never de-
tected TLN-CTF accumulating in PS1
 /  cells, a feature
reminiscent of all reported substrates. Second, using a sensi-
tive Gal4-VP16–based reporter assay (Struhl and Adachi,
2000), we observed no transcriptional activation resulting
from the release of the cytoplasmic domain of TLN E or
when the TMR of TLN was swapped into APP. Pulse-chase
experiments demonstrated furthermore an increased half-life
of TLN and an almost fourfold increase of TLN protein ex-
pression levels in PS1
 /  neurons. These and previous data
(Annaert et al., 2001) clearly suggest that full-length TLN is
delayed in turnover. This coincides with the accumulation
of TLN in distinct organelles in PS1
 /  hippocampal neu-
rons that have features of autophagic vacuoles as they could
be immunolabeled for Apg12p and LC3.
Our findings that TLN is not a  -secretase substrate con-
tradict the hypothesis of Struhl and Adachi (Struhl and
Adachi, 2000), who assayed the substrate requirements for
 -secretase cleavage and proposed that although the particu-
lar sequence of the transmembrane domain is of less impor-
tance, any type I membrane protein can become a substrate
once the ectodomain is sufficiently shortened. To date, TLN
is now the first type I transmembrane protein described that
does not obey this rule.
Because the confocal microscopy approach did not dis-
close the nature of the TLN accumulations, we extended the
analysis to the ultrastructural level and combined a novel
embedding technique (Oorschot et al., 2002) with correla-
tive light immuno-EM. This work revealed autophagic char-
acteristics for the TLN accumulations, which was confirmed
next by labeling with MDC and coimmunostaining for
Apg12p and LC3. Both proteins are members of ubiquitin-
like conjugation systems that sequentially associate and reg-
ulate the formation of autophagic vacuoles (Mizushima et
al., 2002). Furthermore, the absence of late endosomal and
lysosomal marker proteins as well as Lysotracker indicated
that the TLN-positive vacuoles did not yet fuse with the en-
dosomal/lysosomal system and were not acidified. Interest-
ingly, acidification of autophagic vacuoles is essential for the
fusion with lysosomes (Yamamoto et al., 1998). Although
this suggests that TLN accumulations resemble initial au-
tophagic vacuoles, several important differences were no-
ticed. First, their size is exceptionally large (exceeding 2  m)
compared with intermediate autophagic vacuoles (between
400 and 800 nm) (Fig. 5, Fig. 8 D, compare with auto-
phagic vacuoles in catD
 /  neurons; Eskelinen, 2004). Sec-
ond, we never encountered ribosomes, ER membranes, or
mitochondria in these structures, although they represent
the major contents of true autophagic vacuoles. Third, at the
ultrastructural level we never observed a double-limiting
membrane. Still, this should be present if TLN accumula-
tions would originate from an elongating isolation mem-
brane. Because the major criteria are not met, the TLN
accumulations cannot be classified as classic autophagic vac-
uoles, and hence their origin may be uniquely different.
Because intense gold labeling for TLN was recovered on
all internal membranes and because TLN has a plasma
membrane localization, we argued that the TLN accumu-
lations directly originated from the plasma membrane
through phagocytosis or macropinocytosis. Phagocytosis is
an internalization route abundantly used by certain cell
types such as macrophages to take up large particles. As far as
we know, phagocytosis has not been studied in hippocam-
pal neurons, and receptors that trigger this event are not
identified. However, administration of 2- m microbeads (a
widely accepted method to assay phagocytosis) to hippo-
campal neurons in culture resulted over time in a redistribu-
tion and clustering of endogenous TLN toward phagosome
cups. Because we did not observe microbead uptake in HeLa
cells or inhibitory neurons that do not express TLN, these
data strongly suggest that TLN may be a candidate receptor
triggering phagocytosis, as similarly described for the Fc re-
ceptor in macrophages (Greenberg and Grinstein, 2002).
Interestingly, two other characteristics of phagosome ini-
tiation, actin polymerization and PIP2 recruitment, were
equally detected on TLN-positive phagosome cups, suggest-
ing that identical signaling cascades are involved.
The brain area–specific expression of TLN (Yoshihara et
al., 1994) indicates that the TLN-mediated route for degra-
dation is unique to a limited number of neurons including
hippocampal neurons. In this respect, it is interesting to
mention that Lee and coworkers (Wilson et al., 2004) also
demonstrated an accumulation of degradative organelles in
PS1
 /  mixed cortical neurons, but in contrast to hippo-
campal neurons, these were Lamp-2– and catD-positive.
Also, their diameter is much smaller and morphologically
they resemble late autophagic vacuoles reminiscent of those
observed in catD
 /  (this paper) or Lamp-2
 /  cells (Eske-
linen et al., 2002). Similar accumulations of degradative or-
ganelles are seen in PS1/2-deficient fibroblasts (Wilson et
al., 2004), and again in contrast to hippocampal neurons
they could be stained with Lysotracker (unpublished data),
indicating that they fused with (late) endosomes. Finally,
and opposed to Wilson et al. (2004), we did not observe
 -synuclein in the TLN accumulations (Video 2, available
at http://www.jcb.org/cgi/content/full/jcb.200406060/DC1),
further underscoring their unique origin. Because the forma-
tion of TLN-positive phagosome cups triggered by micro-
beads was virtually identical in wild-type and PS1
 /  hippo-
campal neurons (unpublished data), our data collectively
favor the idea that PS1 deficiency affects not the initial, but
final stages of protein degradation at a step before fusion
with prelysosomes or lysosomes. This results in the accumu-
lation of classic late autophagic vacuoles in PS-deficient
mouse embryonic fibroblasts or PS1
 /  cortical neurons
(Wilson et al., 2004), or TLN-positive autophagic vacuole-
like structures originating from phagocytic organelles specif-
ically in the case of hippocampal neurons (this paper).
How PS1 interferes at the molecular level remains to be
investigated in more detail, but data point out already that
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involved in autophagic vacuole maturation is unlikely to be
responsible for this phenomenon because TLN accumula-
tions could not be induced by  -secretase inhibitors and the
TLN phenotype could be rescued by adenoviral expression
of the dominant-negative D257A PS1 mutant. From a med-
ical point of view, this implies that compounds that block
 -secretase activity will not block this function of PS1.
We consistently detected both Apg12p and LC3 on TLN
accumulations, suggesting that the maturation of the TLN-
positive degradative organelle is not accompanied by the
dissociation of the Apg12p–Apg5p conjugate, as would
be expected in normal autophagy. Therefore, PS1 may
be required in the sequence of proper dissociation of the
Apg12p–Apg5p conjugate or in the targeting of LC3 to the
limiting membrane. LC3 exists in two molecular forms,
LC3-I and LC3-II, of which only the latter is specifically
bound to the autophagic vacuole (Kabeya et al., 2000). In-
terestingly, in PS1/2-deficient mouse embryonic fibroblasts,
starvation-induced autophagy resulted in only a low modifi-
cation rate of LC3-I to its membrane-associated LC3-II
form (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200406060/DC1).
Alternatively, our observations may link PS1 to a role in
trafficking as suggested by several papers. For instance, the
cell surface accumulation of APP in PS1
 /  is explained by
a delayed internalization rate of APP (Kaether et al., 2002)
or a retention function for PS1 in the early secretory path-
way (Cai et al., 2003). On the contrary, nicastrin fails to be-
come mature glycosylated in PS-deficient cells, pointing to
a chaperone function for PS1 in early compartments. Al-
though none of these papers resemble or explain the ob-
served blockade in TLN turnover at late stages, they corre-
late with the different subcellular pools of PS1. Indeed, in
neurons PS1 is abundantly distributed in the soma and den-
drites and localizes predominantly to the ER and intermedi-
ate compartment (Annaert et al., 1999). Because we have
demonstrated that this major pool is not associated with
 -secretase activity (Cupers et al., 2001; Maltese et al.,
2001), its abundancy in the intermediate compartment and
COPI-coated organelles (Rechards et al., 2003) supports a
regulatory transport function at this step in the secretory
pathway. In addition, small but significant pools were ob-
served at the cell surface and endosomes/lysosomes (Kaether
et al., 2002; Pasternak et al., 2003; Rechards et al., 2003).
Although these pools may represent the  -secretase active
pools, they may also contribute to APP internalization and
lysosome fusion, respectively.
Accumulation of autophagic vacuoles is observed in an in-
creasing number of neurodegenerative diseases including
Alzheimer’s, Huntington’s, and Parkinson’s disease, and var-
ious prion diseases (for review see Larsen and Sulzer, 2002).
In the case of sporadic Alzheimer’s disease, mainly an activa-
tion of the endocytic pathway and increased delivery of lyso-
somal enzymes to endosomes has been observed in neurons
(Cataldo et al., 1997; Mathews et al., 2002). In most other
cases, a salient feature of autophagic vacuole accumulation is
the presence of lysosomal enzymes such as CatD (Kegel et
al., 2000). In addition, impaired capacity for lysosomal deg-
radation and mistargeting of lysosomal enzymes is clearly the
main reason for autophagic vacuole accumulation in lamp-2
and catD knockouts (Tanaka et al., 2000; Eskelinen et al.,
2002). In the latter model, endogenous TLN also localized
to accumulating autophagic vacuoles, arguing that this is in-
deed the physiological route for TLN turnover in the wild-
type neuron. The accumulation of TLN-positive structures
in PS1
 /  neurons is different, as it was not accompanied
with lysosomal fusion or impaired catD maturation. Also,
their origin is likely not the classical autophagic pathway ini-
tiated by the formation of an isolation membrane, but
maybe by a direct recruitment of autophagic vacuole pro-
tein complexes to the limiting membrane of phagocytic or-
ganelles after fission from the plasma membrane. How these
protein complexes are recruited is currently unknown and
requires further investigation.
In this paper we provide evidence that the TLN interac-
tion links PS1 to a new modulatory role in the maturation
and fusion of late autophagic vacuoles with lysosomes at the
final step of autophagy. This extends the role of PS1 in pro-
tein turnover to at least three independent pathways: in-
tramembrane proteolysis through its  -secretase catalytic
activity, the cytosolic loop domain–associated  -catenin
turnover, and now autophagic vacuole degradation. It will
now become important to define the precise molecular
mechanism and the domains in this multifaceted protein
that are critically involved. Because autophagic vacuole accu-
mulation is observed in several neurodegenerative diseases,
elucidating the role of PS1 in autophagic vacuole maturation
and specifically in their fusion with lysosomes has therefore
not only repercussions for our further understanding of the
cell biology of this protein, but is also anticipated to contrib-
ute to the further understanding of these pathologies.
Materials and methods
Materials and antibodies
Cell culture media were from GIBCO BRL. TOPRO-3 and phalloidin-Alexa
568 (Molecular Probes, Inc.) were used to label nuclei and actin. MDC
was from Sigma-Aldrich.  -Secretase inhibitors were from Calbiochem (X
or L685,458), Elan (DAPT), and AstraZeneca (Compound C).
Polyclonal anti-PS1-NTF (B19.2), -CTF (B32.1) and -TLN (B36.1) have
been described previously (Annaert et al., 2001). B63.1 and B59.1 were
generated using a synthetic peptide mimicking the final 16 and 18 amino
acids of APP and nicastrin, respectively, coupled to KLH (Pierce Chemical
Co.). Mab 9C3 against nicastrin was produced by immunizing the same
peptide in balb/c mice followed by generation of a hybridoma cell line
according to established procedures. We acknowledge the antibody gifts
of anti-calnexin (A. Helenius, ETH Zurich, Zurich, Switzerland), anti-
ergic-53 (J. Saraste, University of Bergen, Bergen, Norway) -LC3 (T. Yoshi-
mori, National Institute of Genetics, Shizuoka-ken, Japan), -Apg12 (N. Mi-
zushima, National Institute for Basic Biology, Okazaki, Japan), PIP2 (G.
Hammond, Cancer Research Institute, London, UK), -LBPA (J. Gruenberg,
University of Geneva, Geneva, Switzerland), and -APP COOH terminus (c
1/6.1; P. Mathews, Nathan Kline Institute, Orangeburg, NY). Mabs to
Lamp-2 (Abl-93) were obtained from Developmental Studies Hybridoma
Bank (Iowa City, Iowa); anti-synaptophysin (cl.7.2) and anti-PS1-CTF
(mAb 5.2) were from R. Jahn (MPI-Göttingen, Göttingen, Germany) and B.
Cordell (Scios Inc., Sunnyvale, CA). mAbs to GM130 and EEA1 were from
BD Biosciences, the transferrin receptor from Zymed Laboratories,  -COP
from Sigma-Aldrich, and BIP from StressGen Biotechnologies.
Constructs and  -secretase luciferase assay
pSFV constructs encoding human APP, murine TLN, and TLN E have
been described previously (Annaert et al., 2001). APP and Notch E were
cloned into the EcoRV site in front of the Gal4VP16 sequence in pIP-
AdApt vector. A construct encoding 10 aa of the ectodomain, the trans-
membrane and cytosolic domains of TLN was obtained by PCR and li-
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next cloned into pIPAdApt and GAL 4VP16 was inserted, resulting in a pI-
PAdApt-SP-TLN E-Gal4-VP16 construct. For the APP/TLNTMR chimaera,
the coding region for APP-TMR was replaced by a PCR fragment encoding
the TLN-TMR.
Luciferase assay
Hela cells were transfected with 200 ng pFRluc plasmid (UAS-responsive
luciferase construct; Stratagene) and 200 ng inducer plasmid using Fu-
GENE (Roche). After 24 h, cells were incubated with or without inhibi-
tors (125 nM), and after 16 h were lysed and assayed (Victor2; Perki-
nElmer).
Primary neuron cultures and metabolic labeling
Human PS1 (in a PS1
 /  background [Qian et al., 1998]), wild-type, PS1
 /
 , PS1
 / , or catD
 /  primary hippocampal neurons were derived from E17
embryos out of heterozygous crosses and were cocultured with a glial
feeder layer (Goslin and Banker, 1991; Annaert et al., 1999). For metabolic
pulse-chase labeling, mixed cortical neuron cultures from wild-type and
PS1
 /  were prepared (Annaert et al., 1999; De Strooper et al., 1998).
At the end, neurons were extracted and immunoprecipitated fractions
were treated with 10 mU endopeptidase H (Boehringer) before SDS-PAGE
(NuPAGE; Invitrogen) and phosphorimaging (Typhoon; PerkinElmer).
For Western blotting, 10–12-d-old hippocampal cultures were har-
vested in PBS, pelleted, resuspended in sample buffer, and separated on
SDS-PAGE. Blots were detected using chemiluminescence (WesternLite;
PerkinElmer) and were scanned using an internal standard (ImageScanner
and TotalLab; Amersham Biosciences).
Adenoviral infection
cDNAs of human wild-type, familial Alzheimer’s disease–linked G384A,
or a dominant-negative D257A mutant PS1 were constructed into the
pIPspADApt6 adaptor plasmid, which contains part of the adenoviral ge-
nome. cDNA encoding eGFP was used as a control. Adenoviruses were
generated by cotransfection with helper cosmid DNA in the PER.C6/E2A
adenoviral packaging cells and titers were determined (Michiels et al.,
2002). For rescue experiments, PS1
 /  hippocampal neurons grown for 4–
6 d on coverslips (at a density of 800–1,200 neurons/coverslip) were in-
fected overnight with different viruses at different MOIs (250–6,000) and
were returned to conditioned medium until fixation on d 15.
Confocal laser scanning microscopy
Primary hippocampal neurons (14–25 d) were fixed in 4% PFA/4% sucrose
in 0.1 M phosphate buffer (30 min, RT), permeabilized by methanol/ace-
tone ( 20 C), 0.5% Triton X-100/PBS, or 0.5% saponin (5 min), and pro-
cessed for indirect immunofluorescence (Annaert et al., 2001). Alexa 488–
and 568–conjugated secondary antibody (Molecular Probes, Inc.) stainings
were detected through a Diaphot 300 (Nikon) connected to a confocal mi-
croscope (MRC 1024; Bio-Rad Laboratories). Data were collected using
Lasersharp 3.0 and processed in Adobe Photoshop 7.0.
For double immunocytochemistry using pAbs of the same host species,
blocked and permeabilized neurons were incubated overnight with biotin-
ylated anti-TLN (B36.1). After blocking free sites with unconjugated Fab
fragments (goat anti–rabbit; Jackson ImmunoResearch Laboratories), cover-
slips were incubated (for 1 h) with Alexa 488–conjugated streptavidin (Mo-
lecular Probes, Inc.) followed by second primary antibody and Alexa 568–
conjugated goat anti–rabbit. In some cases neurons were incubated with bi-
otin (Pierce Chemical Co.), Lysotracker (Molecular Probes, Inc.), or 50 mM
MDC for 30 min at 4 or 37 C before fixation and counterstaining with anti-
TLN. For MDC, analysis was done on a microscope (DMRB; Leica)
equipped with a UV detection filter set (excitation wavelength 380 nm,
emission filter 525 nm), a CCD camera (Photometrics Ltd.), and QuipsFISH
software (Vysis). To study phagocytic uptake, 14-d-old neurons were incu-
bated (4–48 h) with 2- m microbeads (50/cell; Polysciences) in conditioned
medium, briefly washed, fixed, and processed for immunocytochemistry.
Immuno-EM
Fixed neurons were quenched (50 mM NH4Cl, 5 min) and briefly perme-
abilized in 0.2% Triton X-100, followed by incubation with B36.1. After
washing, cells were incubated with Alexa 488–conjugated goat anti–rabbit
IgG to identify TLN accumulations. Positively identified neurons were fur-
ther processed for immuno-EM using a flat embedding technique (Oor-
schot et al., 2002; Koster and Klumperman, 2003). The resulting ultrathin
cryosections were labeled with anti-Alexa 488 IgG (Molecular Probes,
Inc.) according to the protein A–gold technique. Alternatively, cells were
labeled with B36.1 and anti-Lamp-1, scraped and incubated with protein
A–gold (Slot et al., 1991).
Miscellaneous
Microsomal fractions of cortices of E17 wild-type and catD
 /  and catD
 / 
embryos were either analyzed by Western blotting or assayed for  -secre-
tase activity using a cell-free assay. In brief, 2% CHAPS extracts were incu-
bated overnight with recombinant APP-C99, and newly produced amyloid
  was detected by Western blotting (Nyabi et al., 2003).
Online supplemental material
Video 1 shows three-dimensional (3D) reconstructions of the neuronal cell
body displayed in Fig. 9 B for phalloidin-Alexa 568, TLN (green, Alexa
488 goat anti–rabbit), and the merged 3D. Video 2 shows 3D reconstruc-
tions of a neuronal cell body double immunostained for  -synuclein (Al-
exa 568 goat anti–mouse) and TLN (Alexa 488 goat anti–rabbit), as well as
the merged file. Fig. S1 shows a Western blot analysis for LC3 processing
in wild-type, PS1/2 knockout mouse embryonic fibroblasts, and PS1/2
knockout fibroblasts rescued with PS1 wild-type or dominant-negative as-
partate mutants. Online supplemental material available at http://
www.jcb.org/cgi/content/full/jcb.200406060/DC1.
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